title: Infliximab at diagnosis: a sledgehammer to crack a walnut?
authors.forename: Robert B
authors.initials: RB
authors.lastname: Heuschkel
authors.forename: R Mark
authors.initials: RM
authors.lastname: Beattie
authors.forename: Frank M
authors.initials: FM
authors.lastname: Ruemmele
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D007413:Intestinal Mucosa / Q000473:pathology; D012074:Remission Induction
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine